Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR+): study protocol for a randomised controlled trial
Open Access
- 26 January 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 18 (1), 44
- https://doi.org/10.1186/s13063-017-1789-7
Abstract
Smoking is highly prevalent among people who have experience of severe mental ill health, contributing to their poor physical health. Despite the ‘culture’ of smoking in mental health services, people with severe mental ill health often express a desire to quit smoking; however, the services currently available to aid quitting are those which are widely available to the general population and may not be suitable or effective for people with severe mental ill health. The aim of this study is to explore the effectiveness and cost-effectiveness of a bespoke smoking-cessation intervention specifically targeted at people with severe mental ill health. SCIMITAR+ is a multicentre, pragmatic, two-arm, parallel-group, individually randomised controlled trial. We aim to recruit 400 participants aged 18 years and above with a documented diagnosis of bipolar disorder, schizophrenia or schizoaffective disorder who smoke. Potentially eligible participants identified in primary or secondary care will be screened, and baseline data collected. Eligible, consenting participants will be randomly allocated to one of two groups. In the intervention arm, the participant will be assigned a mental health professional trained to deliver smoking-cessation interventions who will work with the participant and participant’s GP or mental health specialist to provide an individually tailored smoking-cessation service. The comparator arm will be usual care – following current NICE guidelines for smoking cessation, in line with general guidance that is offered to all smokers, with no specific adaptation or enhancement in relation to severe mental ill health. The primary outcome will be self-reported smoking cessation at 12 months verified by expired carbon monoxide (CO) measurement. Secondary outcome measures include Body Mass Index at 12 months, the Fagerström Test for Nicotine Dependence, Motivation to Quit questionnaire, SF-12, PHQ-9, GAD-7, EQ-5D-5 L, and health service utilisation at 6 and 12 months. The economic evaluation at 12 months will be conducted in the form of an incremental cost-effectiveness analysis. SCIMITAR+ trial is the largest trial to our knowledge to investigate the effectiveness of a bespoke smoking-cessation service for people with severe mental ill health. International Standard Randomised Controlled Trials Number, ISRCTN72955454 . Registered on 16 January 2015.Keywords
Funding Information
- Health Technology Assessment Programme (11.136.52)
This publication has 14 references indexed in Scilit:
- Smoking and the Reduced Life Expectancy of Individuals With Serious Mental IllnessAmerican Journal of Preventive Medicine, 2016
- Mental health professionals’ perspectives on the implementation of smoke-free policies in psychiatric units across EnglandInternational Journal of Social Psychiatry, 2014
- Change in mental health after smoking cessation: systematic review and meta-analysisBMJ, 2014
- Smoking and Mental Illness — Breaking the LinkNew England Journal of Medicine, 2011
- Tobacco dependence, treatment and smoke-free policies: a survey of mental health professionals' knowledge and attitudesGeneral Hospital Psychiatry, 2009
- Smoke-free policy in acute mental health wards: avoiding the pitfallsGeneral Hospital Psychiatry, 2009
- Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effectSchizophrenia Research, 2005
- Calculation of quality adjusted life years in the published literature: a review of methodology and transparencyHealth Economics, 2004
- Cigarette smoking in patients with schizophreniaThe British Journal of Psychiatry, 2000
- Patients with schizophrenia who smoke: Private disaster, public resourceThe British Journal of Psychiatry, 2000